Nanoparticles Based on Hydrophobic Alginate Derivative as Nutraceutical Delivery Vehicle: Vitamin D₃ Loading

REFERENCES

• Florence, A.T., Hillery, A.M., Hussain, N., Jani, P.U. (1995). Nanoparticles as carriers for oral peptide absorption: Studies on particle uptake and fate. J Controlled Release., 36: 39–46.
   Web of Science ®Google Scholar
• Sozer, N., Kokini, J.L. (2009). Nanotechnology and its applications in the food sector. Trends Biotechnol., 27: 82–89.
   PubMed Web of Science ®Google Scholar
• Williams, S.R., Schlenker, E.D. (2002). Essentials of nutrition and diet therapy. In Absorption, Transport, and Storage. St. Louis: Mosby Press.
   Google Scholar
• Insel, P., Ross, D., McMahon, K., Bernstein, M. (2011). Nutrition. In Digestion of Triglycerides and Phospholipids. Mississauga: Jones & Bartlett Learning Press.
   Google Scholar
• Li, Q., Liu, C.G., Huang, Z.H., Xue, F.F. (2011). Preparation and characterization of nanoparticles based on hydrophobic alginate derivative as carriers for sustained release of Vitamin D3. J Agric Food Chem., 59: 1962–1967.
   PubMed Web of Science ®Google Scholar
• Numerof, P., Sassaman, H.L., Rodgers, A., Schaefer, A.E. (1955). The use of radioactive phosphorus in the assay of vitamin. J Nutr., 55: 13–21.
   PubMed Web of Science ®Google Scholar
• Nordahl, J., Hollberg, K., Mengarelli-Widholm, S., Andersson, G., Reinholt, F.P. (2000). Morphological and functional features of clasts in low phosphate, Vitamin D-deficiency rickets. Calcif Tissue Int., 67: 400–7.
   PubMed Web of Science ®Google Scholar
• Engfedt, B., Hjertqvist, S.O. (1960). Vitamin D deficiency and bone and tooth structure. World Rev Nutr Diet., 2: 185–208.
   PubMedGoogle Scholar
• Gao, Y.L., Liu, S., Wang, K.K., Yu, N. (2009). Uptake of self-assembled sodium alginate nanoparticles in human colon carcinoma Caco-2 cell in vitro. China Pharmacy., 20: 24–26.
   Google Scholar
• Thomas, M.K., Lloyd-Jones, D.M., Thadhani, R.I., Shaw, A.C., Deraska, D.J., Kitch, B.T., Vamvakas, E.C., Dick, I.M., Prince, R.L., Finkelstein, J.S. (1998). Hypovitaminosis D in medical inpatients. N Engl J Med., 338: 777– 83.
   PubMed Web of Science ®Google Scholar
• Jones, G., Dwyer, T., Hynes, K.L., Parameswaran, V., Greenaway, T.M. (2005). Vitamin D insufficiency in adolescent males in southern Tasmania: Prevalence, determinants, and relationship to bone turnover markers. Osteoporos Int., 16: 636– 41.
   PubMed Web of Science ®Google Scholar
• (2003). children. In Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 5th, Favus, M.J.. American Society for Bone and Mineral Research, 173.
   Google Scholar
• Webb, A. R., Pilbeam, C., Hanafin, N., Holick, M. F. (1990). An evaluation of the relative contributions of exposure to sunlight and of diet to the circulating concentrations of 25-hydroxyvitamin D in an elderly nursing home population in Boston. Am J Clin Nutr., 51: 1075–1081.
   PubMed Web of Science ®Google Scholar
• Haden, S. T., Fuleihan, G. E. H., Angell, J. E., Cotran, N. M., LeBoff, M. S. (1999). Calcidiol and PTH levels in women attending an osteoporosis program. Calcif Tissue Res., 64: 275–279.
   Google Scholar
• LeBoff, M. S., Kohlmeier, L., Hurwitz, S., Franklin, J., Wright, J., Glowacki, J. (1999). Occult vitamin D deficiency in postmenopausal US women with acute hip fracture. JAMA, 281: 1505–1511.
   PubMed Web of Science ®Google Scholar
• Ooms, M. E., Lips, P., Roos, J. C., van der Vijgh, W. J. F., Popp-Snijders, C., Bezemer, P. D., Bouter, L. M. (1995). Vitamin D status and sex hormone binding globulin: Determinants of bone turnover and bone mineral density in elderly women. J Bone Miner Res., 10: 1177–1184.
   PubMed Web of Science ®Google Scholar
• Parfitt, A.M., Gallagher, J.C., Heaney, R.P., Johnston, C.C., Neer, R., Whedon, G.D. (1982). Vitamin D and bone health in the elderly. Am J Clin Nutr., 36: 1014–1031.
   PubMed Web of Science ®Google Scholar
• Reichel, H., Koeffler, H.P., Norman, A.W. (1989). The role of the vitamin D endocrine system in health and disease. N Engl J Med., 13: 980–991.
   Google Scholar
• Porter, C.J.H., Charman, W.N. (2001). In vitro assessment of oral lipid based formulations. Adv Drug Deliv Rev., 50: S127–147.
   PubMed Web of Science ®Google Scholar
• Johnson, K.C., Swindell, A.C. (1996). Guidance in setting of drug particle size specifications to minimize variability in absorption. Pharm Res., 13: 1795–1798.
   PubMed Web of Science ®Google Scholar
• Oh, D.M., Curl, R.L., Amidon, G.L. (1993). Estimating the fraction dose absorbed from suspensions of poorly soluble compounds in humans: A mathematical model. Pharm Res., 10: 264–70.
   PubMed Web of Science ®Google Scholar
• Desai, M.P., Labhasetwar, V., Amidon, G.L., Levy, R.J. (1996). Gastrointestinal uptake of biodegradable microparticles: Effect of particle size. Pharm Res., 13: 1838–45.
   PubMed Web of Science ®Google Scholar
• Hussain, N., Jaitley, V., Florence, A.T. (2001). Recent advances in the understanding of uptake of microparticula cross the gastrointestinal lymphatics. Adv Drug Deliv Rev., 50, 107–42.
   PubMed Web of Science ®Google Scholar